Mpox Epidemiology and Vaccine Effectiveness, England, 2023

Hannah Charles; Katie Thorley; Charlie Turner; Kirsty F. Bennet; Nick Andrews; Marta Bertran; Sema Mandal; Gayatri Amirthalingam; Mary E. Ramsay; Hamish Mohammed; Katy Sinka

doi:10.3201/eid3010.240292

Mpox Epidemiology and Vaccine Effectiveness, England, 2023

Hannah Charles^*, Katie Thorley, Charlie Turner, Kirsty F. Bennet, Nick Andrews, Marta Bertran, Sema Mandal, Gayatri Amirthalingam, Mary E. Ramsay, Hamish Mohammed, Katy Sinka

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Abstract

Reported mpox cases in England continued at a low but steady frequency during 2023. Of 137 cases reported in 2023, approximately half were acquired overseas and half were in vaccinated persons. Estimated effectiveness of 2-dose vaccine was 80%, and no vaccinated mpox patient was hospitalized.

Original language	English
Pages (from-to)	2145-2148
Number of pages	4
Journal	Emerging Infectious Diseases
Volume	30
Issue number	10
DOIs	https://doi.org/10.3201/eid3010.240292
Publication status	Published - Nov 2024

Bibliographical note

Publisher Copyright:
© 2024 Centers for Disease Control and Prevention (CDC). All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3201/eid3010.240292

Cite this

@article{22a6b7922ca0474a8341612cb9e3b423,

title = "Mpox Epidemiology and Vaccine Effectiveness, England, 2023",

abstract = "Reported mpox cases in England continued at a low but steady frequency during 2023. Of 137 cases reported in 2023, approximately half were acquired overseas and half were in vaccinated persons. Estimated effectiveness of 2-dose vaccine was 80%, and no vaccinated mpox patient was hospitalized.",

author = "Hannah Charles and Katie Thorley and Charlie Turner and Bennet, {Kirsty F.} and Nick Andrews and Marta Bertran and Sema Mandal and Gayatri Amirthalingam and Ramsay, {Mary E.} and Hamish Mohammed and Katy Sinka",

year = "2024",

month = nov,

doi = "10.3201/eid3010.240292",

language = "English",

volume = "30",

pages = "2145--2148",

journal = "Emerging Infectious Diseases",

issn = "1080-6040",

publisher = "Centers for Disease Control and Prevention (CDC)",

number = "10",

}

TY - JOUR

T1 - Mpox Epidemiology and Vaccine Effectiveness, England, 2023

AU - Charles, Hannah

AU - Thorley, Katie

AU - Turner, Charlie

AU - Bennet, Kirsty F.

AU - Andrews, Nick

AU - Bertran, Marta

AU - Mandal, Sema

AU - Amirthalingam, Gayatri

AU - Ramsay, Mary E.

AU - Mohammed, Hamish

AU - Sinka, Katy

PY - 2024/11

Y1 - 2024/11

N2 - Reported mpox cases in England continued at a low but steady frequency during 2023. Of 137 cases reported in 2023, approximately half were acquired overseas and half were in vaccinated persons. Estimated effectiveness of 2-dose vaccine was 80%, and no vaccinated mpox patient was hospitalized.

AB - Reported mpox cases in England continued at a low but steady frequency during 2023. Of 137 cases reported in 2023, approximately half were acquired overseas and half were in vaccinated persons. Estimated effectiveness of 2-dose vaccine was 80%, and no vaccinated mpox patient was hospitalized.

UR - http://www.scopus.com/inward/record.url?scp=85205018721&partnerID=8YFLogxK

UR - http://www.ncbi.nlm.nih.gov/pubmed/39259828

UR - https://www.mendeley.com/catalogue/641aa295-aeed-3ba8-82e3-e476b6adea14/

U2 - 10.3201/eid3010.240292

DO - 10.3201/eid3010.240292

M3 - Article

C2 - 39259828

AN - SCOPUS:85205018721

SN - 1080-6040

VL - 30

SP - 2145

EP - 2148

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

IS - 10

ER -

Mpox Epidemiology and Vaccine Effectiveness, England, 2023

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this